Attorney Jessica Paluch-Hoerman, founder of TruLaw, has over 28 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.
TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.
Question: What are the side effects of Depo-Provera?
Answer: Depo-Provera side effects such as headaches, vision problems, seizures, and other neurological complications have been associated with an increased risk of developing meningiomas (brain tumors) in women who have used the contraceptive for more than a year.
On this page, we’ll discuss this question in further depth, medical evidence linking Depo-Provera to brain tumors, how to file a Depo-Provera lawsuit, and much more.
The Depo-Provera lawsuit gained momentum following a recent study published in The British Medical Journal that demonstrated a strong association between prolonged Depo-Provera use and meningioma risk.
The research found that using Depo-Provera injections for more than one year was associated with a 5.6-fold (555%) increased risk of developing intracranial meningiomas compared to non-users.
Meningiomas are brain tumors that develop in protective membranes covering the brain and spinal cord, causing serious health complications depending on their size and location.
Legal experts in the Depo-Provera litigation allege that Pfizer, the manufacturer of Depo-Provera, failed to adequately warn healthcare providers and patients about the increased risks.
If you or a loved one developed brain tumors or meningiomas after using Depo-Provera, you may be eligible to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation and determine whether you qualify to join others in filing for the Depo-Provera MDL today.
Our Depo-Provera attorney at TruLaw is dedicated to supporting clients in filing a pharmaceutical injury lawsuit.
With proven success in handling dangerous drug cases, Jessica Paluch-Hoerman provides personalized guidance and strong advocacy to clients affected by brain tumors linked to Depo-Provera use.
Our team understands the devastating impact these conditions have on patients and their families.
Meet our lead Depo-Provera attorney:
At TruLaw, we believe financial concerns should never stand in the way of justice.
That’s why we operate on a contingency fee basis—with this approach, you won’t face any upfront costs for your legal representation.
Our fee is only collected if we are successful in securing compensation on your behalf.
This arrangement not only removes the financial risk of pursuing your case, it allows us to focus our resources on achieving a positive outcome in your case by:
Our investment in representing Depo-Provera users demonstrates our unwavering commitment to seeking the compensation you deserve.
If you or a loved one developed brain tumors or meningiomas after using Depo-Provera, you may be eligible to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation and determine whether you qualify to join others in filing a Depo-Provera lawsuit today.
The prolonged use of Depo-Provera, (medroxyprogesterone acetate), can cause various side effects that range from mild to severe.
While many users experience common reactions after receiving Depo-Provera injections like changes in menstrual bleeding, weight fluctuations, or mood changes, some individuals may develop more serious symptoms that require medical attention.
The initial signs of neurological adverse reactions to Depo-Provera can be subtle and may develop gradually over time.
These symptoms often begin with mild discomfort but should be carefully monitored if they persist or worsen.
Early symptoms of brain tumor development may include, but are not limited to:
Meningiomas can develop in different areas of the brain and cause various symptoms based on the tumor’s location or size.
These tumors typically grow slowly and apply pressure on surrounding brain tissue, which leads to the potential for neurological symptoms to develop gradually over time.
Early detection and medical history evaluations may reduce the need for surgical intervention.
Depending on where the location of the tumor, patients may experience the following symptoms:
If you or a loved one developed brain tumors or meningiomas after using Depo-Provera, you may be eligible to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation and determine whether you qualify to join others in filing a Depo-Provera lawsuit today.
The research published in the The British Medical Journal examined medical records of over 18,000 women who underwent surgery for meningiomas, finding that taking Depo-Provera for more than one year was associated with a 5.6-fold increase in tumor risk compared to non-users.
The study represents one of the most comprehensive investigations into whether Depo-Provera caused meningiomas.
Researchers analyzed extensive patient medical records spanning from 2009 to 2018, specifically focusing on the relationship between various progestogen treatments and the development of intracranial tumors.
Since FDA approval in 1992, approximately 74 million women worldwide have used this contraceptive, with 1–2 million annual users in the U.S. alone.
Key findings about the Depo-Provera brain tumor connection:
Prior to the 2024 findings, several studies had already begun to identify potential concerns regarding the long-term use of progestogen-based contraceptives like Depo-Provera.
These earlier investigations laid the groundwork for understanding the relationship between hormonal contraceptives and meningioma development.
Initial FDA approval in 1974 was revoked due to cervical cancer concerns and was reinstated in 1992 after WHO-led studies disputed carcinogenicity.
Subsequent warnings emerged in the 2000s regarding bone density loss, leading to a 2004 black box warning.
Despite these issues, meningioma risk remained unaddressed in U.S. labeling until 2024 despite earlier signals from European and Canadian regulators.
Depo Provera lawsuits are being filed by individuals across the country who suffered serious side effects after receiving the birth control injection.
TruLaw is currently accepting clients for the Depo Provera lawsuit.
A few reasons to choose TruLaw for your Depo Provera lawsuit include:
If you or a loved one experienced serious side effects after receiving the Depo Provera birth control shot, you may be eligible to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation that can determine if you qualify for the Depo Provera lawsuit today.
Depo-Provera users may experience side effects including headaches, vision problems, seizures, and neurological complications.
The most serious potential side effect is an increased risk of developing meningiomas (brain tumors) after using the contraceptive for more than one year.
Research published in The British Medical Journal shows that using Depo-Provera for more than one year is associated with a 5.6-fold (555%) increased risk of developing intracranial meningiomas.
This significant increase in risk was compared to individuals who did not use the contraceptive.
Early symptoms of meningiomas linked to Depo-Provera include headaches, vision problems, hearing changes, and memory problems.
Additional warning signs may include balance issues and seizures that develop gradually over time.
TruLaw operates on a contingency fee basis, meaning there are no upfront costs for legal representation.
Clients only pay legal fees if the attorneys successfully secure compensation through a settlement or verdict.
Individuals who developed brain tumors or meningiomas after using Depo-Provera may be eligible to seek compensation.
The qualification process involves an evaluation of medical records and usage history through a case assessment.
Depo-Provera’s FDA approval was initially revoked in 1974 due to cervical cancer concerns before being reinstated in 1992.
The contraceptive received a black box warning in 2004 regarding bone density loss, though meningioma risks weren’t addressed in U.S. labeling until 2024.
Managing Attorney & Owner
With over 25 years of legal experience, Jessica Paluch-Hoerman is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share the most reliable, accurate, and up-to-date legal information with our readers!
You can learn more about the Depo-Provera Lawsuit by visiting any of our pages listed below:
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
AFFF Lawsuit claims are being filed against manufacturers of aqueous film-forming foam (AFFF), commonly used in firefighting.
Claims allege that companies such as 3M, DuPont, and Tyco Fire Products failed to adequately warn users about the potential dangers of AFFF exposure — including increased risks of various cancers and diseases.
Suboxone Tooth Decay Lawsuit claims are being filed against Indivior, the manufacturer of Suboxone, a medication used to treat opioid addiction.
Claims allege that Indivior failed to adequately warn users about the potential dangers of severe tooth decay and dental injuries associated with Suboxone’s sublingual film version.
Social Media Harm Lawsuits are being filed against social media companies for allegedly causing mental health issues in children and teens.
Claims allege that companies like Meta, Google, ByteDance, and Snap designed addictive platforms that led to anxiety, depression, and other mental health issues without adequately warning users or parents.
Transvaginal Mesh Lawsuits are being filed against manufacturers of transvaginal mesh products used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI).
Claims allege that companies like Ethicon, C.R. Bard, and Boston Scientific failed to adequately warn about potential dangers — including erosion, pain, and infection.
Bair Hugger Warming Blanket Lawsuits involve claims against 3M — alleging their surgical warming blankets caused severe infections and complications (particularly in hip and knee replacement surgeries).
Plaintiffs claim 3M failed to warn about potential risks — despite knowing about increased risk of deep joint infections since 2011.
Baby Formula NEC Lawsuit claims are being filed against manufacturers of cow’s milk-based baby formula products.
Claims allege that companies like Abbott Laboratories (Similac) and Mead Johnson & Company (Enfamil) failed to warn about the increased risk of necrotizing enterocolitis (NEC) in premature infants.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?